Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maksim Mamonkin

Showing results (21-30 of 53) with videos related to

Pageof 6
Sort By:
Transplantation and Cellular Therapy|January 2, 2023
Apoptosis of Hematopoietic Stem Cells Contributes to Bone Marrow Suppression Following Chimeric Antigen Receptor T Cell TherapyJay A Read, Rayne H Rouce, Feiyan Mo, et al.
Cytotherapy|December 27, 2021
Combinatorial antigen targeting strategies for acute leukemia: application in myeloid malignancyPinar Ataca Atilla, Mary K McKenna, Norihiro Watanabe, et al.
Immunology Letters|October 1, 2013
Differential roles of KLF4 in the development and differentiation of CD8+ T cellsMaksim Mamonkin, Ye Shen, Ping-Hsien Lee, et al.
Human Gene Therapy|March 12, 2020
Adult and Cord Blood-Derived High-Affinity gB-CAR-T Cells Effectively React Against Human Cytomegalovirus InfectionsHenning Olbrich, Sebastian J Theobald, Constanze Slabik, et al.
Cytotherapy|March 20, 2024
Human platelet lysate enhances in vivo activity of CAR-Vδ2 T cells by reducing cellular senescence and apoptosisFeiyan Mo, Chiou-Tsun Tsai, Rong Zheng, et al.
Cancer Immunology Research|October 29, 2017
Reversible Transgene Expression Reduces Fratricide and Permits 4-1BB Costimulation of CAR T Cells Directed to T-cell MalignanciesMaksim Mamonkin, Malini Mukherjee, Madhuwanti Srinivasan, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|July 6, 2017
Treatment of Acute Myeloid Leukemia with T Cells Expressing Chimeric Antigen Receptors Directed to C-type Lectin-like Molecule 1Haruko Tashiro, Tim Sauer, Thomas Shum, et al.
Blood|May 26, 2017
CD7-edited T cells expressing a CD7-specific CAR for the therapy of T-cell malignanciesDiogo Gomes-Silva, Madhuwanti Srinivasan, Sandhya Sharma, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 28, 2017
Comprehensive Approach for Identifying the T Cell Subset Origin of CD3 and CD28 Antibody-Activated Chimeric Antigen Receptor-Modified T CellsMichael Schmueck-Henneresse, Bilal Omer, Thomas Shum, et al.
Nature Communications|February 4, 2026
Enhancing CAR- and TCR-mediated targeting of cancer via an immune synapse-stabilizing receptorChiou-Tsun Tsai, Jorge Ibanez-Vega, Pan Yin, et al.
Pageof 6

Showing results (21-30 of 53) with videos related to

Sort By:
Pageof 6
Transplantation and Cellular Therapy|January 2, 2023
Apoptosis of Hematopoietic Stem Cells Contributes to Bone Marrow Suppression Following Chimeric Antigen Receptor T Cell TherapyJay A Read, Rayne H Rouce, Feiyan Mo, et al.
Cytotherapy|December 27, 2021
Combinatorial antigen targeting strategies for acute leukemia: application in myeloid malignancyPinar Ataca Atilla, Mary K McKenna, Norihiro Watanabe, et al.
Immunology Letters|October 1, 2013
Differential roles of KLF4 in the development and differentiation of CD8+ T cellsMaksim Mamonkin, Ye Shen, Ping-Hsien Lee, et al.
Human Gene Therapy|March 12, 2020
Adult and Cord Blood-Derived High-Affinity gB-CAR-T Cells Effectively React Against Human Cytomegalovirus InfectionsHenning Olbrich, Sebastian J Theobald, Constanze Slabik, et al.
Cytotherapy|March 20, 2024
Human platelet lysate enhances in vivo activity of CAR-Vδ2 T cells by reducing cellular senescence and apoptosisFeiyan Mo, Chiou-Tsun Tsai, Rong Zheng, et al.
Cancer Immunology Research|October 29, 2017
Reversible Transgene Expression Reduces Fratricide and Permits 4-1BB Costimulation of CAR T Cells Directed to T-cell MalignanciesMaksim Mamonkin, Malini Mukherjee, Madhuwanti Srinivasan, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|July 6, 2017
Treatment of Acute Myeloid Leukemia with T Cells Expressing Chimeric Antigen Receptors Directed to C-type Lectin-like Molecule 1Haruko Tashiro, Tim Sauer, Thomas Shum, et al.
Blood|May 26, 2017
CD7-edited T cells expressing a CD7-specific CAR for the therapy of T-cell malignanciesDiogo Gomes-Silva, Madhuwanti Srinivasan, Sandhya Sharma, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 28, 2017
Comprehensive Approach for Identifying the T Cell Subset Origin of CD3 and CD28 Antibody-Activated Chimeric Antigen Receptor-Modified T CellsMichael Schmueck-Henneresse, Bilal Omer, Thomas Shum, et al.
Nature Communications|February 4, 2026
Enhancing CAR- and TCR-mediated targeting of cancer via an immune synapse-stabilizing receptorChiou-Tsun Tsai, Jorge Ibanez-Vega, Pan Yin, et al.
Pageof 6